-
NMPA Promulgated the Technical Guidelines for Clinical Trial of Recombinant Human Coagulation Factor VIII and the Technical Guidelines for Clinical Trial of Recombinant Human Coagulation Factor IX
2019-07-18
NMPA organized the formulation of the Technical Guidelines for Clinical Trial of Recombinant Human Coagulation Factor VIII and the Technical Guidelines for Clinical Trial of Recombinant Human Coagulation Factor IX, which were issued on June 11, 2019.
-
NMPA Promulgated the Guidelines for Clinical Safety Literature Evaluation of Marketed Drugs (Interim)
2019-07-18
NMPA organized the formulation of the Guidelines for Clinical Safety Literature Evaluation of Marketed Drugs (Interim), which was issued on June 18, 2019.
-
General Office of the State Council Issued the Key Tasks for Deepening the Reform of the Pharmaceutical and Healthcare System in 2019
2019-07-18
Recently, the General Office of the State Council issued the Key Tasks for Deepening the Reform of the Pharmaceutical and Healthcare System in 2019.
-
The 2018 Drug Review Annual Report released
2019-07-06
The 2018 Drug Review Annual Report was released on July 1,2019.
-
CDE Released the List of the Second Batch of Overseas New Drugs Urgently Needed in Clinical Settings
2019-07-06
On May 29, 2019, NMPA Center for Drug Evaluation issued the Notice on the Issuance of the List of the Second Batch of Overseas New Drugs Urgently Needed in Clinical Settings.
-
2018 Annual Report for Medical Device Registration Released
2019-07-06
On May 31, 2019, NMPA issued the 2018 Annual Report for Medical Device Registration, which consists of five parts, namely, the situation of medical device registration; the acceptance of medical device registration applications; review and approval of medical device registration; review and approval of registration for innovative medical devices and other products; and management of other registration affairs.
